Christopher S. Walker

3.5k total citations
57 papers, 2.1k citations indexed

About

Christopher S. Walker is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Christopher S. Walker has authored 57 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 26 papers in Psychiatry and Mental health. Recurrent topics in Christopher S. Walker's work include Neuropeptides and Animal Physiology (43 papers), Migraine and Headache Studies (25 papers) and Receptor Mechanisms and Signaling (20 papers). Christopher S. Walker is often cited by papers focused on Neuropeptides and Animal Physiology (43 papers), Migraine and Headache Studies (25 papers) and Receptor Mechanisms and Signaling (20 papers). Christopher S. Walker collaborates with scholars based in New Zealand, United Kingdom and United States. Christopher S. Walker's co-authors include Debbie L. Hay, David R. Poyner, Michael L. Garelja, Rebekah L. Bower, Andrew F. Russo, Erica R. Hendrikse, Tayla A. Rees, Alex C. Conner, Paul W. R. Harris and Andrew Siow and has published in prestigious journals such as Molecular Cell, Neurology and Annals of Neurology.

In The Last Decade

Christopher S. Walker

54 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher S. Walker 1.1k 1.0k 673 467 396 57 2.1k
Helen E. Connor 800 0.7× 914 0.9× 630 0.9× 816 1.7× 452 1.1× 49 2.0k
Maurizio De Fusco 770 0.7× 1.0k 1.0× 1.3k 2.0× 315 0.7× 312 0.8× 32 2.8k
Rosa Gómez‐Villafuertes 526 0.5× 378 0.4× 704 1.0× 285 0.6× 61 0.2× 59 2.2k
Pascal Dournaud 909 0.8× 174 0.2× 1.1k 1.7× 311 0.7× 60 0.2× 58 2.5k
I.J.M. Beresford 743 0.7× 239 0.2× 627 0.9× 299 0.6× 105 0.3× 36 1.3k
Julia Serrano 588 0.5× 209 0.2× 598 0.9× 720 1.5× 49 0.1× 44 1.8k
A. Mauborgne 1.7k 1.5× 166 0.2× 777 1.2× 1.6k 3.5× 162 0.4× 63 2.7k
Delia M. Talos 1.4k 1.2× 732 0.7× 1.1k 1.7× 722 1.5× 56 0.1× 33 3.2k
Luis R. Gardell 1.5k 1.3× 185 0.2× 821 1.2× 2.0k 4.3× 107 0.3× 40 2.9k
M. Markerink–van Ittersum 516 0.5× 191 0.2× 876 1.3× 549 1.2× 37 0.1× 43 1.8k

Countries citing papers authored by Christopher S. Walker

Since Specialization
Citations

This map shows the geographic impact of Christopher S. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Walker more than expected).

Fields of papers citing papers by Christopher S. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Walker. The network helps show where Christopher S. Walker may publish in the future.

Co-authorship network of co-authors of Christopher S. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Walker. A scholar is included among the top collaborators of Christopher S. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Walker. Christopher S. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rees, Tayla A., et al.. (2024). Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354. Frontiers in Pharmacology. 15. 1463313–1463313. 2 indexed citations
2.
Rees, Tayla A., et al.. (2024). Investigation Into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5‐HT1A Signalling. ChemMedChem. 19(15). e202400102–e202400102.
3.
Rees, Tayla A., Song Guo, Simon J. O’Carroll, et al.. (2024). Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor. British Journal of Pharmacology. 181(15). 2655–2675. 6 indexed citations
4.
Rees, Tayla A., et al.. (2024). Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia. The Journal of Headache and Pain. 25(1). 36–36. 10 indexed citations
5.
Finlay, David B., et al.. (2023). RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB1, CB2, GPR18 and GPR55 cannabinoid receptors. British Journal of Pharmacology. 181(14). 2212–2231. 2 indexed citations
6.
Garelja, Michael L., et al.. (2023). Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene‐related peptide responsive receptors. British Journal of Pharmacology. 181(1). 142–161. 9 indexed citations
7.
Hendrikse, Erica R., Tayla A. Rees, Christelle Le Foll, et al.. (2022). Calcitonin receptor antibody validation and expression in the rodent brain. Cephalalgia. 42(9). 815–826. 12 indexed citations
8.
Siow, Andrew, Paul W. R. Harris, Margaret A. Brimble, et al.. (2022). PAC1, VPAC1, and VPAC2 Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies. International Journal of Molecular Sciences. 23(22). 13797–13797. 10 indexed citations
9.
Hendrikse, Erica R., Tayla A. Rees, Michael L. Garelja, et al.. (2022). Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale. International Journal of Molecular Sciences. 23(24). 16035–16035. 8 indexed citations
10.
Siow, Andrew, Tayla A. Rees, Margaret A. Brimble, et al.. (2022). Novel Fluorescently Labeled PACAP and VIP Highlight Differences between Peptide Internalization and Receptor Pharmacology. ACS Pharmacology & Translational Science. 6(1). 52–64. 5 indexed citations
11.
Rees, Tayla A., Andrew F. Russo, Simon J. O’Carroll, Debbie L. Hay, & Christopher S. Walker. (2022). CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons. Frontiers in Physiology. 13. 860037–860037. 20 indexed citations
12.
Ghanizada, Hashmat, Mohammad Al‐Mahdi Al‐Karagholi, Nanna Arngrim, et al.. (2021). Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine. Neurology. 96(20). e2488–e2499. 40 indexed citations
13.
Siow, Andrew, et al.. (2021). Characterisation of agonist signalling profiles and agonist‐dependent antagonism at PACAP‐responsive receptors: Implications for drug discovery. British Journal of Pharmacology. 179(3). 435–453. 28 indexed citations
14.
Siow, Andrew, et al.. (2020). Antagonism of CGRP Signaling by Rimegepant at Two Receptors. Frontiers in Pharmacology. 11. 1240–1240. 43 indexed citations
15.
Hay, Debbie L., Michael L. Garelja, David R. Poyner, & Christopher S. Walker. (2017). Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25. British Journal of Pharmacology. 175(1). 3–17. 286 indexed citations
16.
Woolley, Michael J., Christopher A. Reynolds, John Simms, et al.. (2017). Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs. Biochemical Pharmacology. 142. 96–110. 29 indexed citations
17.
Walker, Christopher S., et al.. (2014). α-Calcitonin gene related peptide (α-CGRP) mediated lipid mobilization in 3T3-L1 adipocytes. Peptides. 58. 14–19. 14 indexed citations
18.
Hay, Debbie L., Christopher S. Walker, & David R. Poyner. (2010). Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges. Endocrine Related Cancer. 18(1). C1–C14. 52 indexed citations
19.
Walker, Christopher S., Alex C. Conner, David R. Poyner, & Debbie L. Hay. (2010). Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends in Pharmacological Sciences. 31(10). 476–483. 125 indexed citations
20.
Walker, Christopher S., Xiaoling Li, Lynda Whiting, et al.. (2010). Mice Lacking the Neuropeptide α-Calcitonin Gene-Related Peptide Are Protected Against Diet-Induced Obesity. Endocrinology. 151(9). 4257–4269. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen E. Connor Breakdown of academic impact, for papers by Maurizio De Fusco Breakdown of academic impact, for papers by Rosa Gómez‐Villafuertes Breakdown of academic impact, for papers by Pascal Dournaud Breakdown of academic impact, for papers by I.J.M. Beresford Breakdown of academic impact, for papers by Julia Serrano Breakdown of academic impact, for papers by A. Mauborgne Breakdown of academic impact, for papers by Delia M. Talos Breakdown of academic impact, for papers by Luis R. Gardell Breakdown of academic impact, for papers by M. Markerink–van Ittersum
Rankless by CCL
2026